by | May 27, 2023 | Publications
Int J Mol Sci. 2023 May 13;24(10):8731. doi: 10.3390/ijms24108731. ABSTRACT CD30, a member of the tumor necrosis factor receptor superfamily, plays roles in pro-survival signal induction and cell proliferation in peripheral T-cell lymphoma (PTCL) and adult T-cell...
by | May 27, 2023 | Publications
Pathogens. 2023 May 5;12(5):682. doi: 10.3390/pathogens12050682. ABSTRACT BACKGROUND: The prevalence of human T-lymphotropic virus type-1 (HTLV-1) infection is higher in women, and sexual intercourse has been described as an important route of male-to-female...
by | May 27, 2023 | Publications
Pathogens. 2023 May 19;12(5):735. doi: 10.3390/pathogens12050735. ABSTRACT Human T lymphotropic virus-1 (HTLV-1) was the first identified oncoretrovirus, which infects and establishes a persistent infection in approximately 10-20 million people worldwide. Although...
by | May 26, 2023 | Publications
Transplant Proc. 2023 May 23:S0041-1345(23)00247-6. doi: 10.1016/j.transproceed.2023.03.076. Online ahead of print. ABSTRACT BACKGROUND: Constructing serologic profiles of donors is the first step in establishing traceability in the donation and transplant process....
by | May 25, 2023 | Publications
Eur J Med Chem. 2023 May 3;256:115449. doi: 10.1016/j.ejmech.2023.115449. Online ahead of print. ABSTRACT Cells latently infected with human immunodeficiency virus type 1 (HIV-1) prevent people living with HIV-1 from obtaining a cure to the infectious disease. Latency...
by | May 24, 2023 | Publications
Med Microbiol Immunol. 2023 May 24. doi: 10.1007/s00430-023-00767-8. Online ahead of print. ABSTRACT Adult T-cell leukemia/lymphoma (ATLL) is pathogen-caused cancer that is progressed after the infection by human T-cell leukemia virus type 1. Four significant subtypes...
